Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0136 USD | -2,52% | -2,86% | -78,75% |
Omzet 2022 | 16,84 15,67 | Omzet 2023 | 18,22 16,95 | Marktkapitalisatie | 1,28 mln. 1,19 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -76 mln. -70,71 mln. | Nettowinst (verlies) 2023 | 53 mln. 49,31 mln. | EV/omzet 2022 | 4.528.434 x |
Nettoschuld 2022 | 68,36 mln. 63,6 mln. | Nettoschuld 2023 | 43,37 mln. 40,36 mln. | EV/omzet 2023 | 2.451.077 x |
K/w-verhouding 2022 |
-0,05
x | K/w-verhouding 2023 |
1,2
x | Werknemers | 38 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 100% |
Recentste transcriptie over Evofem Biosciences, Inc.
1 dag | -2,52% | ||
1 week | -2,86% | ||
Lopende maand | -2,86% | ||
1 maand | -35,24% | ||
3 maanden | -56,69% | ||
6 maanden | -80,29% | ||
Lopend jaar | -78,75% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 01-01-13 | |
Ivy Zhang
DFI | Director of Finance/CFO | 46 | 01-03-18 |
Amy Raskopf
IRC | Investor Relations Contact | - | 01-02-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 01-01-13 | |
Kim Kamdar
BRD | Director/Board Member | 56 | 01-01-18 |
Colin Rutherford
BRD | Director/Board Member | 65 | 01-01-18 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
07-05-24 | 0,0136 | -2,52% | 568 467 |
06-05-24 | 0,0139 | +15,83% | 1 324 803 |
03-05-24 | 0,012 | -7,69% | 2 495 055 |
02-05-24 | 0,013 | -6,47% | 1 499 167 |
01-05-24 | 0,0139 | -0,71% | 607 348 |
uitgestelde koers OTC Markets, 07 mei 2024 om 21:59 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-78,75% | 827K | |
+33,43% | 700 mld. | |
-5,12% | 358 mld. | |
+19,59% | 330 mld. | |
+4,89% | 287 mld. | |
+15,89% | 236 mld. | |
+6,70% | 202 mld. | |
-9,08% | 197 mld. | |
+4,26% | 161 mld. | |
-3,54% | 157 mld. |